Exodus Point Capital Management, LP Biomarin Pharmaceutical Inc Transaction History

Exodus Point Capital Management, LP

$14.6 Billion
Q4 2024

A detailed history of Exodus Point Capital Management, LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 49,817 shares of BMRN stock, worth $3.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

49,817

Previous 78,311 36.39%

Holding current value

$3.6 Million

Previous $5.5 Million 40.52%

% of portfolio

0.02%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$61.93 - $70.49 $1.76 Million - $2.01 Million	-28,494 Reduced 36.39%	49,817 $3.27 Million
Q3 2024 Nov 12, 2024	BUY	$69.02 - $93.84 $5.41 Million - $7.35 Million	78,311 New	78,311 $5.5 Million
Q3 2023 Nov 09, 2023	SELL	$85.07 - $94.48 $5.07 Million - $5.63 Million	-59,626 Reduced 25.96%	170,017 $15 Million
Q2 2023 Aug 10, 2023	BUY	$86.68 - $100.3 $4.48 Million - $5.19 Million	51,707 Added 29.06%	229,643 $19.9 Million
Q1 2023 May 11, 2023	BUY	$87.74 - $117.27 $5.24 Million - $7 Million	59,730 Added 50.53%	177,936 $17.3 Million
Q4 2022 Feb 13, 2023	SELL	$80.93 - $108.63 $6.12 Million - $8.21 Million	-75,610 Reduced 39.01%	118,206 $12.2 Million
Q3 2022 Nov 10, 2022	BUY	$82.16 - $96.94 $6.77 Million - $7.98 Million	82,346 Added 73.87%	193,816 $16.4 Million
Q2 2022 Aug 19, 2022	BUY	$71.48 - $86.85 $6.46 Million - $7.85 Million	90,341 Added 427.57%	111,470 $9.24 Million
Q1 2022 May 13, 2022	SELL	$74.28 - $92.69 $1.46 Million - $1.82 Million	-19,648 Reduced 48.18%	21,129 $1.63 Million
Q4 2021 Feb 11, 2022	BUY	$71.72 - $91.47 $2.35 Million - $3 Million	32,789 Added 410.48%	40,777 $3.6 Million
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $597,262 - $682,734	7,988 New	7,988 $617,000
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $1.26 Million - $1.42 Million	-16,748 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $725,329 - $880,237	-9,706 Reduced 36.69%	16,748 $1.27 Million
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $979,799 - $1.22 Million	-13,494 Reduced 33.78%	26,454 $2.32 Million
Q3 2020 Nov 16, 2020	SELL	$71.87 - $131.03 $7.02 Million - $12.8 Million	-97,708 Reduced 70.98%	39,948 $3.04 Million
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $10 Million - $15.7 Million	126,125 Added 1093.79%	137,656 $17 Million
Q1 2020 May 15, 2020	BUY	$71.37 - $96.85 $822,967 - $1.12 Million	11,531 New	11,531 $974,000
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $295,642 - $397,302	-4,600 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $310,040 - $391,506	4,600 New	4,600 $310,000

Others Institutions Holding BMRN

# of Institutions

626

Shares Held

183M

Call Options Held

Put Options Held

1.67M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Biomarin Pharmaceutical Inc Transaction History